comparemela.com

Latest Breaking News On - Ascendum capital - Page 1 : comparemela.com

SetPoint Medical raises $80M for nerve stimulation tech that treats autoimmune disease

SetPoint Medical Raises $80M in Funding

Metronom Health, Dinova Medtech looking to launch continuous glucose monitoring device in China

Credit: Metronom Health Chinese medical device innovation hub Dinova Medtech and US-based medical device company Metronom Health have established a joint venture to develop and sell a continuous glucose monitoring system in China.  WHY IT MATTERS Traditional fingerstick glucose meters can only provide information about intermittent glucose levels and the pain that comes with finger pricking can potentially reduce patients adherence. By inserting a sensor into the subcutaneous tissue along with a transmitter that sends the data to a smart device, CGMs can provide continuous glucose information to detect glycemic variability. According to a press release, Metronom Health has developed a minimally invasive CGM system that uses proprietary Opto-enzymatic technology – in contrast to most CGMs that use electrochemical technology – to capture both high and low ranges of a patient s glucose profile. The company claims that this will be done with high accuracy and also asserts th

DCP, Sequoia China lead Series B round for medical devices firm Valgen

DCP, Sequoia China lead Series B round for medical devices firm Valgen Source: Valgen Medtech May 6, 2021 Greater China-focused private equity firm DCP and tech investment bellwether Sequoia Capital China have co-led a Series B round of financing for Valgen Medtech, a developer of treatment technologies for heart diseases in China. The investment size is said to be “hundreds of millions of US dollars.” Lake Bleu Capital, a healthcare-focused asset management platform; Chinese transcatheter heart valve medical devices maker Venus Medtech; China Life Healthcare Fund, an investment vehicle of Beijing-based insurer China Life Insurance; Hong Kong’s healthcare investor Ascendum Capital participated in the round. Existing shareholder Qiming Venture Partners re-upped in the round.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.